Sort
82,697 grants matching “vaccine development”
Study of Influenza Incidence, Diagnosis, Treatment Efficacy, Vaccine Effectivenes
$799,929Nestor Sosa · Gorgas Memorial Institute Of Health St · U01 · FY2016 · IP
HIV-specific ex-vivo expanded T cell therapy (HXTC) to Deplete the Latent Reservoir of Persistent HIV Infection
$799,908David M. Margolis · Univ Of North Carolina Chapel Hill · R01 · FY2016 · HL
Maintenance of the SPF Breeding Colonies at Yerkes National Primate Research Center
$799,816Joyce Kimberly Cohen · Emory University · U42 · FY2020 · OD
Maintenance of the SPF Breeding Colonies at Yerkes National Primate Research Center: Husbandry and Management Core
$799,816Joyce Kimberly Cohen · Emory University · U42 · FY2020 · OD
AKT as a Biomarker of Ovarian Cancer Progression and a Target for Therapy
$799,787Joseph Robert Testa · Fox Chase Cancer Center · P50 · FY2008 · CA
Modulation of innate and adaptive immunity of filoviruses in macaques
$799,758Thomas William Geisbert · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI
Humoral Correlates of Protection Against HIV
$799,742Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R01 · FY2014 · AI
BIOMEDICAL RESEARCH INFRASTRUCTURE AT ALABAMA STATE UNI*
$799,729Alabama State University · P20 · FY2005 · MD
Host-pathogen interactions during hospital adaptation of MRSA
$799,626Bo Shopsin · New York University School Of Medicine · R01 · FY2022 · AI
ITR: Gene Design for Vaccines and Therapeutic Phages
$799,623Steven Skiena · Suny At Stony Brook · · FY2003 · CSE
New Algorithms and Software for Mass Spectrometric Analysis of Intact Proteins and Complexes
$799,604Marshall Wayne Bern · Protein Metrics, Llc · R44 · FY2021 · GM
Protective Human Monoclonal Antibodies to HIV-1
$799,591Susan B Zolla-Pazner · New York University School Of Medicine · R01 · FY2014 · HL
Immunogenetics of COVID-19 Immune Response
$799,523Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2025 · AI
Investigating and identifying the heterogeneity in COVID-19 misinformation exposure on social media among Black and Rural communities to inform precision public health messaging
$799,507Sharath Chandra Guntuku · University Of Pennsylvania · R01 · FY2022 · MD
A Novel Live Non-replicating Universal Vaccine for Influenza
$799,507Sally R. Sarawar · Biomedical Research Instit/ Southern, Ca · R01 · FY2015 · AI
Effect of immunization route and prior immunity for a live attenuated varicella AIDS vaccine
$799,482Vicki L Traina-Dorge · Tulane University Of Louisiana · R01 · FY2018 · AI
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
$799,422Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2014 · CA
mAbs and vaccines against SARS CoV-2
$799,403Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
A Novel Th17-inducing Mucosal Vaccine for Tuberculosis
$799,386Shabaana A. Khader · Washington University · R01 · FY2020 · AI
Evaluation of the Interplay between HIV and COVID-19 in a large urban safety-net HIV clinic
$799,372Monica Gandhi · University Of California, San Francisco · R01 · FY2021 · AI
Developing small molecule therapeutics for Ebola hemorrhagic fever virus
$799,333Arnab Basu · Microbiotix, Inc · R01 · FY2014 · AI
O-Specific Polysaccharide Responses and Cholera
$799,285Edward T. Ryan · Massachusetts General Hospital · R37 · FY2025 · AI
Novel diagnostic tools and animal model system for study human/animal interface of COVID-19
$799,280Ying Fang · University Of Illinois At Urbana-Champaign · R01 · FY2021 · AI
Retroviral infection and new modulators of the MHCII pathway
$799,185Tatyana V. Golovkina · University Of Chicago · R01 · FY2024 · AI
Immune Modulation/Hematopoietic Cell Transplantation
$799,185Robert Jon Soiffer · Dana-Farber Cancer Inst · U19 · FY2010 · AI